Showing results (61-70 of 220) with videos related to

Sort By:
Pageof 22
European Urology|July 30, 2011
Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancerMarco Roscigno, Maurizio Brausi, Axel Heidenreich, et al.
The Journal of Urology|June 11, 2005
Permeation of hypericin in spheroids composed of different grade transitional cell carcinoma cell lines and normal human urothelial cellsAnn Huygens, Appolinary R Kamuhabwa, Tania Roskams, et al.
Urologic Oncology|January 24, 2021
C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumabEduard Roussel, Lisa Kinget, Annelies Verbiest, et al.
Urology|August 10, 2010
New developments in the treatment of localized penile cancerEduardo Solsona, Amit Bahl, Steven B Brandes, et al.
European Urology|January 30, 2013
Influence of preoperative and postoperative pelvic floor muscle training (PFMT) compared with postoperative PFMT on urinary incontinence after radical prostatectomy: a randomized controlled trialInge Geraerts, Hendrik Van Poppel, Nele Devoogdt, et al.
BJU International|February 1, 2005
In vivo accumulation of different hypericin ion pairs in the urothelium of the rat bladderAnn Huygens, Appolinary R Kamuhabwa, Ben van Cleynenbreugel, et al.
Central European Journal of Urology|November 2, 2020
Uro-oncology in the era of social distancing: the principles of patient-centered online consultations during the COVID-19 pandemicRoman Sosnowski, Hubert Kamecki, Steven Joniau, et al.
Journal of Biomedical Optics|February 2, 2011
Biodistribution and photodynamic effects of polyvinylpyrrolidone-hypericin using multicellular spheroids composed of normal human urothelial and T24 transitional cell carcinoma cellsJoachim Vandepitte, Mieke Roelants, Ben Van Cleynenbreugel, et al.
Radiation Oncology (London, England)|August 10, 2007
Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility studySara Junius, Karin Haustermans, Barbara Bussels, et al.
European Urology|June 10, 2008
Degarelix: a novel gonadotropin-releasing hormone (GnRH) receptor blocker--results from a 1-yr, multicentre, randomised, phase 2 dosage-finding study in the treatment of prostate cancerHendrik Van Poppel, Bertrand Tombal, Jean J de la Rosette, et al.
Pageof 22